Quotation Are Invited For Pharmaceutical Items in United Arab Emirates

Work Detail

Quotation are invited for 5 Years Tasharok Contract for Pharmaceutical Items - Ipr# 126028404 (P1) - T# 22600896/Sma Description: 1: [520-19680] ABATACEPT 250 MG/15 ML INJECTION - 1 EA 2: [520-24317] ABEMACICLIB 100 MG TABLET - 1 EA 3: [520-24318] ABEMACICLIB 150 MG TABLET - 1 EA 4: [520-20118] ABIRATERONE 250 MG TABLET - 1 EA 5: [520-23048] ABROCITINIB 200 MG TABLET - 1 EA 6: [520-23047] ABROCITINIB 100 MG TABLET - 1 EA 7: [520-00556] ACARBOSE 100 MG TABLET - 1 EA 8: [520-20728] ACECLOFENAC 100 MG TABLET - 1 EA 9: [520-00637] ACETAZOLAMIDE 500 MG INJECTION - 1 EA 10: [520-00001] ACETAZOLAMIDE 250 MG TABLET - 1 EA 11: [520-00638] ACETYLCHOLINE 1% (10 MG/ML) INTRAOCULAR INJECTION (2 ML) - 1 EA 12: [520-01223] ACETYLCYSTEINE 20% (200 MG/ML) ORAL & INHALATION SOLUTION (2ML) - 1 EA 13: [520-00923] ACETYLCYSTEINE 20% (200 MG/ML) INJECTION (10ML) - 1 EA 14: [520-19093] ACETYLCYSTEINE 200 MG ORAL GRANULES SACHET - 1 EA 15: [520-00164] ACITRETIN 10 MG CAPSULE - 1 EA 16: [520-00062] ACTIVATED CHARCOALGRANULES FOR ORAL SUSPENSION (50 G) - 1 EA 17: [520-00639] ACYCLOVIR 250 MG INJECTION - 1 EA 18: [520-01022] ACYCLOVIR 5% CREAM - 1 EA 19: [520-00561] ACYCLOVIR 200 MG/5ML (125 ML) ORAL SUSPENSION - 1 EA 20: [520-01023] ACYCLOVIR 3% (5 G) EYE OINTMENT - 1 EA 21: [520-24257] ADALIMUMAB (HYRIMOZ) 40 MG/0.8 ML PREFILLED PEN.- - 1 EA 22: [520-19344] ADALIMUMAB (HUMIRA) 40 MG/0.4 ML PREFILLED PEN - 1 EA 23: [520-23624] ADALIMUMAB (HUMIRA) 20 MG/0.2 ML PREFILLED SYRINGE KIT - 1 EA 24: [520-01279] ADAPALENE 0.1 % (30G) GEL - 1 EA 25: [520-22331] ADAPALENE/BENZOYL PEROXIDE 0.1%/2.5% (30G) GEL - 1 EA 26: [520-00902] ADENOSINE 3MG/ML (2ML) INJECTION - 1 EA 27: [520-20313] ADO-TRASTUZUMAB EMTANSINE (KADCYLA) 160MG INJECTION - 1 EA 28: [520-20312] ADO-TRASTUZUMAB EMTANSINE (KADCYLA) 100MG INJECTION - 1 EA 29: [520-19516] AESCIN 20 MG TABLET - 1 EA 30: [520-19124] AESCIN/DIETHYLAMINE SALICYLATE 1%/5% (100 G) GEL - 1 EA 31: [520-24508] AFLIBERCEPT (EYLEA HD) 8 MG/0.07 ML (114.3 MG/ML) INTRAVITREAL INJECTION - 1 EA 32: [520-20364] AGOMELATINE 25 MG TABLET - 1 EA 33: [520-22332] AJMALINE Online Response Required: Yes Closing: 04/05/2026 10:00:00 Time Limit for Expressing Interest: 04/05/2026 10:00:00 In order to participate in this RFQ/Tender, please register online on www.eSupply.dubai.gov.ae, which is the official procurement portal of Dubai Government. Supplier Registration: https://esupply.dubai.gov.ae/esop/guest/go/public/registration?locale=en_GB&country=AE&customGuest= Tender Link : https://esupply.dubai.gov.ae/esop/toolkit/opportunity/current/239405/detail.si

Contact Information